Amgen Inc. buy Royal Bank of Canada
Start price
07.04.26
/
50%
€292.40
Target price
07.04.27
€320.90
Performance (%)
24.00%
Price
16:37
€360.05
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada currently has a performance of 24.00%. A total of €2.52 was paid as dividends for this prediction. This prediction currently runs until 07.04.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 0.999% | 0.999% |
| iShares Core DAX® | 0,44 % | 5,90 % |
| iShares Nasdaq 100 | 1,06 % | 0,92 % |
| iShares Nikkei 225® | 1,77 % | 1,23 % |
| iShares S&P 500 | 0,37 % | 1,92 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen (AMGN) had its price target raised by Royal Bank Of Canada from $360.00 to $370.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat